Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 273 publications
Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.
Journal: Journal of the American Society of Nephrology : JASN
Published: October 10, 2025
Authors' Reply: Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.
Journal: Journal of the American Society of Nephrology : JASN
Published: October 10, 2025
Safety and Tolerability of Sotagliflozin Among Kidney Transplant Recipients.
Journal: Transplantation
Published: September 23, 2025
Rationale and Design of the SOTA-THROMBOSIS Trial (ATRU-VI): Antithrombotic Activities of Sotagliflozin compared to Empagliflozin.
Journal: Journal of cardiovascular pharmacology
Published: August 01, 2025
Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease.
Journal: Journal of managed care & specialty pharmacy
Published: June 27, 2025
Unlocking the Potential of Sotagliflozin in Diabetes Mellitus targeting SGLT 1 & SGLT 2: A Comprehensive Review.
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
Published: June 22, 2025
Sotagliflozin attenuates atrial oxidative stress and the susceptibility to atrial fibrillation by activating the NRF2/HO-1 pathway.
Journal: International immunopharmacology
Published: June 19, 2025
In type 2 diabetes with CKD and additional CV risk factors, sotagliflozin reduced total MACE vs. placebo at a median 14 mo.
Journal: Annals of internal medicine
Published: June 02, 2025
Comparison chart: Some drugs for HFrEF.
Journal: The Medical letter on drugs and therapeutics
Published: May 19, 2025
Sotagliflozin: Two Birds with One Stone?
Journal: Cardiovascular drugs and therapy
Published: May 19, 2025
Last Updated: 10/31/2025